| Title： | Guidelines for Evaluating the Management Effectiveness of National Organized Centralized Procurement of Drugs in Medical Institutions |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Administration |
| Countries and regions： | China |
| Guidelines users： | Pharmacists, physicians and other related medical personnel in medical institutions at all levels and types and managers of health administration and medical security authorities. |
| Evidence classification method： | The evaluation indicators of hospital management evaluation guidelines could be divided into research-based indicators and policy-based indicators. Research-based indicators take various types of research literature as the main source of evidence, and the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) method is used to evaluate the quality of the issue evidence system. Policy-oriented indicators take relevant national departmental documents as the main source of evidence, and the evidence is graded according to the “Legislative Law”. As the literature referenced in this guide is dominated by non-classical evidennce, the type of evidence will be taken into account in the evaluation process ,and the quality of non-classical evidence will be evaluated without the tools for classical research evidence. |
| Development unit： | Precision Pharmacy Working Committee of the Chinese Pharmacists Association |
| Registration time: | 2023-04-24 |
| Registration number： | PREPARE-2023CN277 |
| Purpose of the guideline: | This guide based on relevant laws and regulations and the best available evidence, provides the basis for a comprehensive and objective assessment of the effectiveness of the whole process of management of drugs with national centralized procurement in medical institutions, with the aim of standardizing the management behavior of national centralized procurement of drugs in medical institutions, effectively implementing the national centralized drug procurement policy, protecting clinical treatment needs and promoting rational use of drugs. |
